MARKET

VBIV

VBIV

Vbi Vaccines
NASDAQ
0.7870
+0.0075
+0.96%
After Hours: 0.7647 -0.0223 -2.83% 19:16 07/12 EDT
OPEN
0.7799
PREV CLOSE
0.7795
HIGH
0.8098
LOW
0.7405
VOLUME
152.30K
TURNOVER
0
52 WEEK HIGH
1.540
52 WEEK LOW
0.4500
MARKET CAP
22.57M
P/E (TTM)
-0.1136
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VBIV last week (0701-0705)?
Weekly Report · 07/08 09:45
Weekly Report: what happened at VBIV last week (0624-0628)?
Weekly Report · 07/01 09:45
VBI Vaccines Shareholders Approve Board and Accountant
TipRanks · 06/26 00:37
VBI Vaccines Announces Results of Annual General Meeting
VBI Vaccines Inc. Announced the voting results from its annual general meeting of shareholders held on June 25, 2024. VBI is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. The total number of common shares voted was an aggregate of 13,879,327.
Barchart · 06/25 15:15
Weekly Report: what happened at VBIV last week (0617-0621)?
Weekly Report · 06/24 09:48
Weekly Report: what happened at VBIV last week (0610-0614)?
Weekly Report · 06/17 09:45
Weekly Report: what happened at VBIV last week (0603-0607)?
Weekly Report · 06/10 09:46
Weekly Report: what happened at VBIV last week (0527-0531)?
Weekly Report · 06/03 09:47
More
About VBIV
VBI Vaccines Inc. is a commercial-stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, the Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The Company is focused on targeting and overcoming significant infectious diseases, including hepatitis B (HBV), coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). Its product pipeline includes an approved vaccine and multiple late- and early-stage investigational programs. PreHevbrio is its approved vaccine for hepatitis B. Its Prophylactic Candidates for coronavirus disease include VBI-2901, VBI-2905, VBI-2902, and others. VBI-1501 is its Prophylactic Candidate for cytomegalovirus. VBI-2601 and VBI-1901 are the therapeutic candidates for HBV and GBM.

Webull offers VBI Vaccines Inc stock information, including NASDAQ: VBIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VBIV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VBIV stock methods without spending real money on the virtual paper trading platform.